IL125075A - Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections - Google Patents

Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections

Info

Publication number: IL125075A
Authority: IL; Israel
Prior art keywords: penciclovir; famciclovir; immunosuppressants; treatment; combination
Prior art date: 1996-01-26

Application number

IL12507597A

Other languages

English (en)

Other versions

IL125075A0 (en

Original Assignee

Novartis Int Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-01-26

Filing date

1997-01-24

Publication date

2003-02-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10787583&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL125075(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-01-24 Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd

1999-01-26 Publication of IL125075A0 publication Critical patent/IL125075A0/xx

2003-02-12 Publication of IL125075A publication Critical patent/IL125075A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

IL12507597A 1996-01-26 1997-01-24 Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections IL125075A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9601544.1A GB9601544D0 (en)	1996-01-26	1996-01-26	Pharmaceuticals
PCT/GB1997/000226 WO1997026882A1 (en)	1996-01-26	1997-01-24	Nucleoside analogs in combination therapy of herpes simplex infections

Publications (2)

Publication Number	Publication Date
IL125075A0 IL125075A0 (en)	1999-01-26
IL125075A true IL125075A (en)	2003-02-12

Family

ID=10787583

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL12507597A IL125075A (en)	1996-01-26	1997-01-24	Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections

Country Status (25)

Country	Link
US (5)	US6514980B1 (xx)
EP (1)	EP0876146B1 (xx)
JP (1)	JP2000507211A (xx)
KR (1)	KR19990081966A (xx)
CN (1)	CN1133433C (xx)
AR (1)	AR005551A1 (xx)
AT (1)	ATE238796T1 (xx)
AU (1)	AU713202B2 (xx)
BR (1)	BR9707304A (xx)
CY (1)	CY2421B1 (xx)
CZ (1)	CZ297841B6 (xx)
DE (1)	DE69721484T2 (xx)
DK (1)	DK0876146T3 (xx)
ES (1)	ES2199339T3 (xx)
GB (1)	GB9601544D0 (xx)
HU (1)	HU226793B1 (xx)
IL (1)	IL125075A (xx)
NO (1)	NO316355B1 (xx)
NZ (1)	NZ326839A (xx)
PL (1)	PL187076B1 (xx)
PT (1)	PT876146E (xx)
TR (1)	TR199801439T2 (xx)
TW (1)	TW493985B (xx)
WO (1)	WO1997026882A1 (xx)
ZA (1)	ZA97608B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW438585B (en)	1995-02-06	2001-06-07	Astra Ab	Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) *	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
US7591945B2 (en) *	2003-02-07	2009-09-22	Gambro Lundia Ab	Support device for containers in extracorporeal blood treatment machines
CN101193643A (zh) *	2005-03-25	2008-06-04	Alt解决方案公司	端粒酶阳性细胞中端粒长度的调节和癌症治疗
CA2609303A1 (en) *	2005-05-18	2006-11-23	Alt Solutions, Inc.	Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
US20110065655A1 (en) *	2009-09-17	2011-03-17	Karry Whitten	Therapeutic composition to treat lesions caused by herpes simplex virus
GB201907305D0 (en) *	2019-05-23	2019-07-10	Douglas Pharmaceuticals Ltd	Treatment of conditions
CN112704154A (zh) *	2020-12-24	2021-04-27	中国人民解放军66399部队	一种用于治疗宠物猫疱疹病毒的营养膏

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3317384A (en) *	1964-06-08	1967-05-02	Upjohn Co	Treatment of topical viral infections with glucocorticoids and nucleosides
US3322627A (en) *	1964-09-03	1967-05-30	Merck & Co Inc	Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
GB9001886D0 (en) *	1990-01-26	1990-03-28	Beecham Group Plc	Pharmaceutical formulation
GB9015051D0 (en) *	1990-07-07	1990-08-29	Beecham Group Plc	Pharmaceutical treatment
DE69306545T2 (de)	1992-10-01	1997-04-03	Wellcome Found	Tucaresol als Mittel zur Immunopotentierung
GB9426021D0 (en)	1994-12-22	1995-02-22	Smithkline Beecham Plc	Pharmaceuticals
TW438585B (en) *	1995-02-06	2001-06-07	Astra Ab	Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
GB9601544D0 (en) *	1996-01-26	1996-03-27	Smithkline Beecham Plc	Pharmaceuticals
US6136835A (en) *	1999-05-17	2000-10-24	The Procter & Gamble Company	Methods of treatment for viral infections

1996
- 1996-01-26 GB GBGB9601544.1A patent/GB9601544D0/en active Pending
1997
- 1997-01-24 EP EP97901694A patent/EP0876146B1/en not_active Revoked
- 1997-01-24 ES ES97901694T patent/ES2199339T3/es not_active Expired - Lifetime
- 1997-01-24 HU HU9900945A patent/HU226793B1/hu not_active IP Right Cessation
- 1997-01-24 PL PL97327917A patent/PL187076B1/pl not_active IP Right Cessation
- 1997-01-24 ZA ZA97608A patent/ZA97608B/xx unknown
- 1997-01-24 WO PCT/GB1997/000226 patent/WO1997026882A1/en not_active Ceased
- 1997-01-24 BR BR9707304A patent/BR9707304A/pt not_active IP Right Cessation
- 1997-01-24 TR TR1998/01439T patent/TR199801439T2/xx unknown
- 1997-01-24 DK DK97901694T patent/DK0876146T3/da active
- 1997-01-24 AR ARP970100303A patent/AR005551A1/es not_active Application Discontinuation
- 1997-01-24 IL IL12507597A patent/IL125075A/xx not_active IP Right Cessation
- 1997-01-24 CZ CZ0234098A patent/CZ297841B6/cs not_active IP Right Cessation
- 1997-01-24 KR KR1019980705684A patent/KR19990081966A/ko not_active Ceased
- 1997-01-24 NZ NZ326839A patent/NZ326839A/en not_active IP Right Cessation
- 1997-01-24 AU AU15506/97A patent/AU713202B2/en not_active Ceased
- 1997-01-24 CN CNB971918694A patent/CN1133433C/zh not_active Expired - Fee Related
- 1997-01-24 JP JP9526681A patent/JP2000507211A/ja active Pending
- 1997-01-24 DE DE69721484T patent/DE69721484T2/de not_active Expired - Fee Related
- 1997-01-24 PT PT97901694T patent/PT876146E/pt unknown
- 1997-01-24 AT AT97901694T patent/ATE238796T1/de active
- 1997-02-26 TW TW086102357A patent/TW493985B/zh active
1998
- 1998-07-23 NO NO19983402A patent/NO316355B1/no not_active IP Right Cessation
2000
- 2000-07-26 US US09/626,015 patent/US6514980B1/en not_active Expired - Lifetime
2001
- 2001-06-19 US US09/884,715 patent/US20040185433A1/en not_active Abandoned
2004
- 2004-01-08 CY CY0400005A patent/CY2421B1/xx unknown
2005
- 2005-04-14 US US11/105,842 patent/US20050222016A1/en not_active Abandoned
2008
- 2008-07-02 US US12/217,193 patent/US20080287389A1/en not_active Abandoned
2010
- 2010-08-30 US US12/871,563 patent/US20100323952A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR9707304A (pt)	1999-07-20
DE69721484D1 (de)	2003-06-05
HUP9900945A3 (en)	2001-02-28
US6514980B1 (en)	2003-02-04
DE69721484T2 (de)	2004-02-26
ZA97608B (en)	1998-07-24
AU1550697A (en)	1997-08-20
ES2199339T3 (es)	2004-02-16
PL187076B1 (pl)	2004-05-31
US20080287389A1 (en)	2008-11-20
TR199801439T2 (xx)	1998-10-21
AR005551A1 (es)	1999-06-23
CN1133433C (zh)	2004-01-07
JP2000507211A (ja)	2000-06-13
CN1209748A (zh)	1999-03-03
HU226793B1 (en)	2009-10-28
US20040185433A1 (en)	2004-09-23
HK1016475A1 (en)	1999-11-05
CZ234098A3 (cs)	1999-02-17
GB9601544D0 (en)	1996-03-27
EP0876146B1 (en)	2003-05-02
IL125075A0 (en)	1999-01-26
HUP9900945A2 (hu)	1999-07-28
DK0876146T3 (da)	2003-08-11
CY2421B1 (en)	2004-11-12
PT876146E (pt)	2003-09-30
NO983402D0 (no)	1998-07-23
US20100323952A1 (en)	2010-12-23
KR19990081966A (ko)	1999-11-15
US20050222016A1 (en)	2005-10-06
TW493985B (en)	2002-07-11
WO1997026882A1 (en)	1997-07-31
AU713202B2 (en)	1999-11-25
NZ326839A (en)	2001-02-23
EP0876146A1 (en)	1998-11-11
NO316355B1 (no)	2004-01-19
NO983402L (no)	1998-07-23
ATE238796T1 (de)	2003-05-15
PL327917A1 (en)	1999-01-04
CZ297841B6 (cs)	2007-04-11

Publication	Publication Date	Title
ZA9710339B (en)	1998-11-17	Xanthines and their therapeutic use
ZA976603B (en)	1999-01-25	Azolo triazines and pyrimidines
GR3024699T3 (en)	1997-12-31	Use of dideoxy nucleoside analogues in the treatment of viral infections.
AU4289100A (en)	2000-10-16	Dihydropyrimidines and their use in the treatment of hepatitis
ZA975288B (en)	1998-01-05	The use of TCET in the prophylaxis and treatment of allergies.
IL113409A (en)	1999-08-17	Preparation of famciclovir and penciclovir
IL125075A (en)	2003-02-12	Penciclovir or famciclovir in combination with immunosuppressants in the treatment of herpes simplex virus infections
AU6748090A (en)	1991-06-26	Use of caffeine in the treatment of herpes simplex virus infections
EP0797440A4 (en)	2000-07-05	TREATING AUTOIMMUNE DISEASES WITH THE AID OF 2-AMINOPURINE DERIVATIVES
IL127871A0 (en)	1999-10-28	Azolo triazines and pyrimidines
FI953298L (fi)	1995-08-28	5-alkoksi(1,2,4)triatsolo(1,5-c)pyrimidiini-2(3H)-tioniyhdisteitä ja niiden käyttö 2,2'-ditiobis(5-alkoksi(1,2,4)triatsolo/1,5-C/-pyrimidiini) ja 2-klorosulfonyyli-5-alkoksi/1,2,4/-triatsolo/1,5-c/yhdisteiden valmistuksessa
GR3023611T3 (en)	1997-08-29	Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
CY2339B1 (en)	2004-02-06	Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
GB9419692D0 (en)	1994-11-16	Treatment of herpes infections
GB9603657D0 (en)	1996-04-17	Improvements in the treatment of vaginal infections
IL127350A0 (en)	1999-10-28	Combinations comprising VX478 zidovudine and/or 1592U89 for use in the treatment of HIV
GB9317915D0 (en)	1993-10-13	Tableware and other utensils for the disabled
EP0630897A3 (en)	1995-03-01	3-hydroxy-4-hydroxymethyl-2-methylene-cyclopentyl purines and pyrimidines.
HK1046862A1 (zh)	2003-01-30	用於治疗单纯疱疹病毒的2-氨基-苯并恶嗪酮
SI0876146T1 (en)	2004-02-29	Nucleoside analogs in combination therapy of herpes simplex infections
AU1436901A (en)	2001-05-08	Treatment and prevention of herpes simplex infections
LV10385B (en)	1995-04-20	Use of quinons in the treatment of cancer or aids
IL150163A0 (en)	2002-12-01	Azolo triazines and pyrimidines
CA2244268A1 (en)	1997-07-31	Nucleoside analogs in combination therapy of herpes simplex infections
GB9312427D0 (en)	1993-07-28	Condensation reduction in rear view extermal mirrors

Legal Events

Date	Code	Title
2003-07-31	FF	Patent granted
2003-07-31	KB	Patent renewed
2007-05-21	KB	Patent renewed
2011-01-31	KB	Patent renewed
2015-09-24	MM9K	Patent not in force due to non-payment of renewal fees